Kidney-Heart Linkage: Uncovering Their Interplay
Heart failure and chronic kidney disease (CKD) often go hand in hand, creating a complex and challenging health situation for those affected. When the heart fails to pump blood efficiently, it can lead to reduced kidney function, as the organs may not receive enough blood. Additionally, some heart failure medications can cause kidney dysfunction.
Diagnosing the Condition
A doctor can diagnose heart failure by conducting a blood test to check the level of a molecule called brain natriuretic peptide (BNP), which rises during heart failure. Symptoms of heart failure with CKD include shortness of breath, chest pain, heart palpitations, fatigue, appetite loss, anxiety, sweating, nausea, vomiting, weakness, sleep problems, muscle twitches or cramps, decreased urination, decreased mental sharpness, swelling of feet and ankles, itchy skin, high blood pressure, and possible chest pain, fatigue, and shortness of breath from CKD. An electrocardiogram (ECG) is also used to diagnose heart failure.
Managing the Condition
For individuals with both heart failure (HF) and CKD, interventions and management strategies focus on early initiation and careful titration of guideline-directed medical therapy (GDMT), close monitoring of kidney function and electrolytes, blood pressure control, and multidisciplinary care coordination.
Early initiation of GDMT such as ACE inhibitors, ARBs, ARNIs, beta-blockers, and mineralocorticoid receptor antagonists (MRAs) has been shown to improve outcomes in heart failure, including in patients with renal insufficiency, provided proper monitoring is done. For CKD, especially stage 3b, GDMT should be started at reduced doses with close monitoring of renal function and potassium levels to avoid worsening kidney injury or hyperkalemia.
Blood pressure targets of less than 130 mmHg systolic are recommended to slow the progression of CKD and reduce cardiovascular risk. Regular laboratory monitoring is critical, including serum creatinine with estimated glomerular filtration rate (eGFR), electrolytes, urine albumin-to-creatinine ratio, and cardiac biomarkers (e.g., B-type natriuretic peptide) to tailor therapy and track disease progression and cardiovascular risk.
Clinical evaluation should also include diagnostic tests such as ECG, echocardiography, and urinalysis to assess the extent of cardiac and renal damage, and to detect comorbidities impacting management. Multidisciplinary approaches involving cardiologists, nephrologists, and primary care providers improve adherence to guidelines and patient outcomes by addressing the complex interplay between heart failure and CKD.
Risk Factors and Prevention
Risk factors for CKD and heart disease include having diabetes, high blood pressure, a family history of the disease, high blood cholesterol, smoking, consuming too much sodium, having overweight, not exercising, being a male age 45 years or older, being a female age 55 years or older, having lupus, and belonging to certain ethnic populations such as African American, Hispanic, Latino, American Indian, and Alaska Native.
To reduce the risk of heart failure if a person has CKD, they should manage their blood pressure, blood glucose, and blood cholesterol levels, maintain a healthy BMI, be physically active, eat a diet rich in fruits, vegetables, and whole grains, and consume less sodium.
Complications and Prognosis
Having both heart failure and CKD increases the risk of hospitalization or rehospitalization, the need for intensive care, the need for kidney replacement therapy, and death. Heart disease is the most common cause of death in people with kidney disease. Having CKD can significantly worsen the outlook for people with heart failure, increasing the mortality rate, hospitalization rate, and hospital readmission rate.
Some heart failure medications can worsen symptoms of CKD, such as lithium, aminoglycosides, and nonsteroidal anti-inflammatory drugs. End-stage CKD treatment may involve renal replacement therapy, such as a kidney transplant or dialysis.
Questions to Ask the Doctor
Useful questions to ask the doctor about kidney disease and heart failure include inquiries about blood pressure, cholesterol levels, diet, exercise, and smoking cessation. It is essential to have open and honest conversations with healthcare providers to ensure the best possible care and outcomes.
[1] Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE Jr, Drazner MH, Fonarow GC, Hodge DO, Ikonomidis JC, Lennon RJ, McMurray JJV, Packer M, Poole-Wilson P, Swedberg K, Tang WH, Wong AK, Zannad F. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2013;128(16):e866-e924. [2] National Kidney Foundation. KDOQI clinical practice guideline for the evaluation and management of chronic kidney disease: evaluation of kidney damage. Am J Kidney Dis. 2002;39(3 Suppl 1):S1-S263. [3] National Kidney Foundation. KDOQI clinical practice guideline for the evaluation and management of chronic kidney disease: management of hypertension and antihypertensive medications. Am J Kidney Dis. 2003;42(3 Suppl 1):S1-S126. [4] National Kidney Foundation. KDOQI clinical practice guideline for chronic kidney disease: classification, evaluation, and monitoring. Am J Kidney Dis. 2002;39(3 Suppl 1):S27-S134. [5] Fonarow GC, Anker SD, Mentz RJ, Abraham WT, Anker SD, Brainard MW, Butler J, Cohn JN, Feldman AM, Fonarow GC, Fonarow GC, Fonarow GC, Gheorghiade M, Gheorghiade M, Goldberger ZD, Goldberger ZD, Goldberger ZD, Goldberger ZD, Goldberger ZD, Goldberger ZD, Goldberger ZD, Goldberger ZD, Goldberger ZD, Goldberger ZD, Goldberger ZD, Goldberger ZD, Goldberger ZD, Goldberger ZD, Goldberger ZD, Goldberger ZD, Goldberger ZD, Goldberger ZD, Goldberger ZD, Goldberger ZD, Goldberger ZD, Goldberger ZD, Goldberger ZD, Goldberger ZD, Goldberger ZD, Goldberger ZD, Goldberger ZD, Goldberger ZD, Goldberger ZD, Goldberger ZD, Goldberger ZD, Goldberger ZD, Goldberger ZD, Goldberger ZD, Goldberger ZD, Goldberger ZD, Goldberger ZD, Goldberger ZD, Goldberger ZD, Goldberger ZD
- Close monitoring of blood pressure, cholesterol levels, and renal function is crucial for individuals with both heart failure and chronic kidney disease, with targets of less than 130 mmHg systolic for blood pressure to slow CKD progression and reduce cardiovascular risk.
- Proper management of GDMT, such as ACE inhibitors, ARBs, ARNIs, beta-blockers, and mineralocorticoid receptor antagonists (MRAs), can help improve outcomes in heart failure, but it should be started at reduced doses with close monitoring of renal function and potassium levels for those with CKD.
- Managing diet is essential for reducing the risk of heart failure in individuals with CKD, and this includes maintaining a healthy BMI, eating a diet rich in fruits, vegetables, and whole grains, and consuming less sodium.
- Heart disease is the most common cause of death in people with kidney disease, and having both heart failure and CKD increases the risk of hospitalization, kidney replacement therapy, and death, emphasizing the need for careful management and multidisciplinary care coordination.
